Filing Details
- Accession Number:
- 0001562180-18-001025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-16 11:54:12
- Reporting Period:
- 2018-02-15
- Accepted Time:
- 2018-02-16 11:54:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1560241 | G1 Therapeutics Inc. | GTHX | Pharmaceutical Preparations (2834) | 263648180 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1706853 | Rajesh Malik | C/O G1 Therapeutics, 79 Tw Alexander Dr. 4501 Research Commons, Suite 100 Research Triangle Park NC 27709 | Ch. Medical Officer & Svp R&D | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-15 | 2,890 | $0.30 | 2,890 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-02-15 | 886 | $0.39 | 3,776 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-15 | 3,776 | $20.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2018-02-15 | 886 | $0.00 | 886 | $0.39 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2018-02-15 | 2,890 | $0.00 | 2,890 | $0.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,280 | 2023-12-05 | No | 4 | M | Direct | |
| 0 | 2023-08-29 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- All shares underlying this option have vested.
Billionaire Hedge Funds
